A total of 175 journals in BioMed Central's publishing portfolio now have impact iactors in the recently published Journal Citation Report 2015, of which 104 journals rank in the top half of their categories.
The next big thing in wearable technology may show up right inside your mouth.
MedStar Heart & Vascular Institute at MedStar Washington Hospital Center was the first in the Washington metropolitan region to implant the newly approved WATCHMAN Device. The new device is designed to prevent stroke in high-risk patients with atrial fibrillation who are seeking an alternative to blood-thinning medication. Blood thinners are effective in stroke risk reductions for A-fib patients, but many cannot tolerate these drugs because of the risk of bleeding. Now, there's a new option.
The Helmholtz Senate has given the green light for the Association's involvement in the Helmholtz International Beamline, a new kind of experimentation station at the X-ray laser European XFEL in Hamburg, Germany. As the leading institutes of the international HIB user consortium, the Helmholtz-Zentrum Dresden-Rossendorf and DESY were able to secure funding in the amount of 30 million Euros for this project. The majority of the funding will go to Helmholtz International Beamline for Extreme Fields.
By the end of the year, contextually smart mobile services will be available to consumers and professional drivers as Cinia, Multiprint, Vediafi and Technical Research Centre of Finland VTT Ltd. commercialize new smart mobile services that are currently being piloted. New services will be used for producing and receiving contextually local voice and information services on vehicle operation, services, weather conditions and traffic disturbances, for example.
Adis, a leading global provider of drug information, has taken a major step forward in its quest to make expertly written drug information more accessible, with the launch of a new platform AdisInsight. The platform presents a unique, joined-up view of current evidence on drug treatments being developed worldwide -- how well they work, how safe they are, who is working on them, and how soon they will be available -- in a single database.
Empa, the Swiss Federal Laboratories for Materials Science and Technology, is part of the collaborative 'European Nanomedicine Characterization Laboratory,' a European project funded by the EU framework program 'Horizon 2020.' Its goal is to reach a level of international excellence in nanomedicine characterization for diseases like cancer, diabetes, inflammatory diseases or infections. This competence will be made accessible to all organizations developing candidate nanomedicines prior to their submission to regulatory agencies to get approval for clinical trials and, later on, for marketing authorization.
SAGE and SingHealth have today announced a new partnership to publish SingHealth's flagship journal, Proceedings of Singapore Healthcare, as of September 2015. The journal will remain owned by SingHealth but will be published by SAGE.
A new research project at the Cluster of Excellence Cognitive Interactive Technology (CITEC) in Bielefeld University focuses on the development of a mobile adaptive assistance system in the form of intelligent glasses that provide unobtrusive and intuitive support in everyday situations.
The just-completed international Celtic Plus CoMoSeF project involved the development of data exchange between vehicles and infrastructure. The resulting communication system provides drivers with real time information on road weather, road conditions and incidents.